Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
Hamed HA, Yacoub A, Park MA, Eulitt PJ, Dash R, Sarkar D, Dmitriev IP, Lesniak MS, Shah K, Grant S, Curiel DT, Fisher PB, Dent P. Hamed HA, et al. Among authors: eulitt pj. Mol Ther. 2010 Jun;18(6):1130-1142. doi: 10.1038/mt.2010.29. Epub 2010 Feb 23. Mol Ther. 2010. Retraction in: Mol Ther. 2024 Aug 29:S1525-0016(24)00542-2. doi: 10.1016/j.ymthe.2024.08.020. PMID: 20179672 Free PMC article. Retracted.
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY. Rose TL, et al. Among authors: eulitt p. Br J Cancer. 2021 Oct;125(9):1251-1260. doi: 10.1038/s41416-021-01488-6. Epub 2021 Jul 22. Br J Cancer. 2021. PMID: 34294892 Free PMC article.
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, Hayward MC, Salazar AH, Milowsky MI, Wobker SE, McGinty K, Millburn MV, Eisner JR, Kim WY. Rose TL, et al. Among authors: eulitt p. Br J Cancer. 2022 May;126(8):1237. doi: 10.1038/s41416-022-01781-y. Br J Cancer. 2022. PMID: 35277660 Free PMC article. No abstract available.
Perioperative systemic therapy for bladder cancer.
Eulitt PJ, Bjurlin MA, Milowsky MI. Eulitt PJ, et al. Curr Opin Urol. 2019 May;29(3):220-226. doi: 10.1097/MOU.0000000000000600. Curr Opin Urol. 2019. PMID: 30855376 Review.
Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
Eulitt PJ, Altun E, Sheikh A, Wong TZ, Woods ME, Rose TL, Wallen EM, Pruthi RS, Smith AB, Nielsen ME, Whang YE, Kim WY, Godley PA, Basch EM, David GU, Ramirez J, Deal AM, Rathmell WK, Chen RC, Bjurlin MA, Lin W, Lee JK, Milowsky MI. Eulitt PJ, et al. Clin Genitourin Cancer. 2020 Oct;18(5):378-386.e1. doi: 10.1016/j.clgc.2020.02.008. Epub 2020 Mar 6. Clin Genitourin Cancer. 2020. PMID: 32147364
18 results